Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 27th, 2023%
A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines. . . . → Read More: Infographic – More US Support for Childhood Vaccines Than Covid-19
By Alan, on May 19th, 2023%
A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death. . . . → Read More: $60M Challenge Seeks Biomarkers, Models to Counter Aging Stress
By Alan, on May 17th, 2023%
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection
By Alan, on May 9th, 2023%
A study of people with type 2 diabetes shows those using a digital diabetes management system made fewer hospital visits than non-users over a 12-month period. . . . → Read More: Digital Diabetes System Shown to Cut Health Care Use
By Alan, on April 18th, 2023%
A venture capital company supporting developers of digital technologies in health care says it raised $460 million to invest in early-stage digital health businesses. . . . → Read More: New Funds to Invest in Digital Health Start-Ups
By Alan, on April 10th, 2023%
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.” . . . → Read More: Biotech Group Blasts Reproductive Drug Ruling
By Alan, on March 31st, 2023%
A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery
By Alan, on February 10th, 2023%
A clinical trial has begun testing a commercially-available flu vaccine administered with a painless patch device against conventional syringe injection delivery. . . . → Read More: Clinical Trial Underway Testing Influenza Vaccine Patch
By Alan, on January 18th, 2023%
A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues. . . . → Read More: Biotech, Academic Lab Partner on Microbiome-Safe Products
By Alan, on January 9th, 2023%
Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|